Results 41 to 50 of about 14,990 (249)

Pictorial essay: Allergic bronchopulmonary aspergillosis

Indian Journal of Radiology and Imaging, 2011
Allergic bronchopulmonary aspergillosis (ABPA) is the best-known allergic manifestation of Aspergillus-related hypersensitivity pulmonary disorders. Most patients present with poorly controlled asthma, and the diagnosis can be made on the basis of a ...
Ritesh Agarwal, Ajmal Khan, Mandeep Garg, Ashutosh N Aggarwal, Dheeraj Gupta   +4 more
doaj   +1 more source

Prevalence and fungal profile of pulmonary aspergillosis in immunocompromised and immunocompetent patients of a tertiary care hospital [PDF]

, 2014
Background: Aspergillus is a fungus which may present an array of pulmonary manifestations, depending on the patient’s immunological and physiological state. Although the incidence of pulmonary aspergillosis occurs primarily in immunocompromised patients
Prakash Ved, Mishra Prem P, Verma Shashi K, Sinha Shivani, Sharma Mahendra
core   +1 more source

Allergic bronchopulmonary aspergillosis: Indian scenario

Indian Journal of Allergy Asthma and Immunology, 2019
Aspergillus is ubiquitous, occurring in mycelial form and grows at 15-530C and humid conditions. Pulmonary aspergillosis is a clinical spectrum of lung disease caused by the fungus Aspergillus.
Rajendra Prasad, Rishabh Kacker, Nikhil Gupta   +2 more
doaj   +1 more source

Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review

Therapeutic Advances in Respiratory Disease, 2020
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction (HR) mediated by antigens to Aspergillus fumigatus. It is estimated that 2–15% of patients with cystic fibrosis (CF) and between 1% and 5% of asthmatics develop ABPA, affecting
Isabel Eraso, S. Sangiovanni, E. Morales, L. Fernández-Trujillo   +3 more
semanticscholar   +1 more source

Management of allergic bronchopulmonary aspergillosis: a review and update

Therapeutic Advances in Respiratory Disease, 2012
Since the first description of allergic bronchopulmonary aspergillosis (ABPA) in the 1950s there have been numerous studies that have shed light on the characteristics and immunopathogenesis of this disease.
Mahboobeh Mahdavinia, Leslie C. Grammer
doaj   +1 more source

Inhalación de esporas de Aspergillus fumigatus induce en ratones una inflamación de las vías aéreas similar a la observada en equinos con Obstrucción Recurrente de las Vías Aéreas [PDF]

, 2012
The aim of this study was to determine if mice exposed to Aspergillus (A.) fumigatus spores develop airway inflammation in a similar manner to Recurrent Airway Obstruction (RAO) in horses.
Barría, M., Diedrichs, K., Folch, H., Morán, G., Ojeda, G., Ortloff Trautmann, Alexander   +5 more
core   +1 more source

Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses

European Respiratory Journal
Background The International Society for Human and Animal Mycology (ISHAM) working group proposed recommendations for managing allergic bronchopulmonary aspergillosis (ABPA) a decade ago. There is a need to update these recommendations due to advances in
R. Agarwal, I. Sehgal, V. Muthu, D. W. Denning, Arunaloke Chakrabarti, Kathirvel Soundappan, M. Garg, S. Rudramurthy, S. Dhooria, Darius Armstrong-James, K. Asano, J. Gangneux, S. H. Chotirmall, Helmut J. F. Salzer, James D. Chalmers, Cendrine Godet, Marcus Joest, Iain Page, P. Nair, P. Arjun, Raja Dhar, K. Jat, Geethu Joe, U. Krishnaswamy, Joseph L. Mathew, V. N. Maturu, Anant Mohan, A. Nath, Dharmesh Patel, J. Savio, Puneet Saxena, Rajeev Soman, B. Thangakunam, C. Baxter, F. Bongomin, William J Calhoun, Oliver A. Cornely, Jo A Douglass, C. Kosmidis, J. F. Meis, Richard B Moss, Alessandro C. Pasqualotto, Danila Seidel, Rosanne Sprute, K. Prasad, A. Aggarwal   +45 more
semanticscholar   +1 more source

Current Approach in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis

Frontiers in Pediatrics, 2020
Allergic bronchopulmonary aspergillosis (ABPA) is a complex pulmonary disorder characterized by a hypersensitivity reaction to Aspergillus fumigatus, and almost always seen in patients with cystic fibrosis (CF) and asthma.
B. Sunman, D. Ademhan Tural, B. Ozsezen, N. Emiralioğlu, E. Yalçın, U. Özçelik   +5 more
semanticscholar   +1 more source

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

Clinical and Experimental Neuroimmunology, Volume 17, Issue 1, February 2026.
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa, Ema Rodrigues, Hiroyuki Murai   +2 more
wiley   +1 more source

Specific Antibodies to Recombinant Allergens of \u3cem\u3eAspergillus fumigatus\u3c/em\u3e in Cystic Fibrosis Patients with ABPA [PDF]

, 2006
Background Aspergillus fumigatus, a widely distributed fungus, has been implicated in causing life threatening infections as well as severe asthma and allergic diseases in man.
Bansal, Naveen K., Knutsen, Alan P., Kurup, Viswanath P., Moss, Richard B.   +3 more
core   +1 more source